This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Disorders of lipid metabolism
  • /
  • 2019 ESC/EAS guidelines for the management of dysl...

2019 ESC/EAS guidelines for the management of dyslipidaemias

Read time: 1 mins
Last updated:30th Aug 2019
Status: Live
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification.

These guidelines has been developed for healthcare professionals to facilitate informed communication with individuals about their CV risk and the benefits of adopting and sustaining a healthy lifestyle, and of early modification of their lipid-related CV risk.


Read full guideline